Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
2.590
-0.090 (-3.36%)
At close: Aug 4, 2025, 4:00 PM
2.700
+0.110 (4.25%)
After-hours: Aug 4, 2025, 7:52 PM EDT
Intercept Pharmaceuticals Market Cap
Aptevo Therapeutics has a market cap or net worth of $9.60 million as of August 4, 2025. Its market cap has increased by 299.94% in one year.
Market Cap
9.60M
Enterprise Value
12.14M
1-Year Change
299.94%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $160.50M to $9.60M, a decrease of -94.02%. That is a compound annual growth rate of -26.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.10M | -50.00% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.27% |
| Dec 31, 2021 | 38.40M | -74.67% |
| Dec 31, 2020 | 151.60M | 413.90% |
| Dec 31, 2019 | 29.50M | 2.08% |
| Dec 31, 2018 | 28.90M | -68.17% |
| Dec 29, 2017 | 90.80M | 85.69% |
| Dec 30, 2016 | 48.90M | -69.53% |
| Jul 20, 2016 | 160.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |